|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Research and development | |
| General and administrative | |
| Credit loss - related party accounts receivable | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expense), net: | |
| Unrealized loss on short-term investments | |
| Interest and dividend income | |
| Total other income, net | |
| Net Loss | |
| Unrealized gain on short-term investments | |
| Comprehensive loss | |
| Net loss per share of common stock, basic | |
| Net loss per share of common stock, diluted | |
| Weighted-average shares used in net loss per share calculation, basic | |
| Weighted-average shares used in net loss per share calculation, diluted |
Loading...
